Sleep duration and cardiometabolic risk factors among individuals with type 2 diabetes
- 1 January 2015
- journal article
- research article
- Published by Elsevier in Sleep Medicine
- Vol. 16 (1) , 119-125
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Implications of Sleep Restriction and Recovery on Metabolic OutcomesThe Journal of Clinical Endocrinology & Metabolism, 2012
- Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studiesEuropean Heart Journal, 2011
- Sleep duration and cardiometabolic risk: A review of the epidemiologic evidenceBest Practice & Research Clinical Endocrinology & Metabolism, 2010
- Quantity and Quality of Sleep and Incidence of Type 2 DiabetesDiabetes Care, 2009
- Association Between Sleep and Blood Pressure in MidlifeArchives of internal medicine (1960), 2009
- The Association Between Sleep Duration and Weight Gain in Adults: A 6-Year Prospective Study from the Quebec Family StudySLEEP, 2008
- Association between Reduced Sleep and Weight Gain in WomenAmerican Journal of Epidemiology, 2006
- Short Sleep Duration as a Risk Factor for HypertensionHypertension, 2006
- Brief Communication: Sleep Curtailment in Healthy Young Men Is Associated with Decreased Leptin Levels, Elevated Ghrelin Levels, and Increased Hunger and AppetiteAnnals of Internal Medicine, 2004
- Impact of sleep debt on metabolic and endocrine functionThe Lancet, 1999